Similar articles

• Translating Science into Survival: Report on the Fifth International Cancer Immunotherapy Conference.

  Diken M, Kepp O, Brodsky AN. Diken M, et al. Cancer Immunol Res. 2020 Jan;8(1):3-6. doi: 10.1158/2326-6066.CIR-19-0888. Cancer Immunol Res. 2020. PMID: 31909729
• A reality check of the accelerated approval of immune-checkpoint inhibitors.

  Gill J, Prasad V. Gill J, et al. Nat Rev Clin Oncol. 2019 Nov;16(11):656-658. doi: 10.1038/s41571-019-0260-y. Epub 2019 Aug 5. Nat Rev Clin Oncol. 2019. PMID: 31383994 No abstract available.
• Acquired Resistance to Immune Checkpoint Inhibitors.

  Schoenfeld AJ, Hellmann MD. Schoenfeld AJ, et al. Cancer Cell. 2020 Apr 13;37(4):443-455. doi: 10.1016/j.ccell.2020.03.017. Cancer Cell. 2020. PMID: 32289269 Free PMC article. Review.
• Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Twenty-First Century Edition.

  Konety BR. Konety BR. Urol Clin North Am. 2020 Feb;47(1):xiii. doi: 10.1016/j.ucl.2019.10.001. Urol Clin North Am. 2020. PMID: 31757305 No abstract available.
• Principles of Immunotherapy in Melanoma.

  Onitilo AA, Wittig JA. Onitilo AA, et al. Surg Clin North Am. 2020 Feb;100(1):161-173. doi: 10.1016/j.suc.2019.09.009. Epub 2019 Nov 1. Surg Clin North Am. 2020. PMID: 31753110 Review.